Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48−0.04 (-8.36%)
Close on Nov 17, 2026Market cap $3.14MP/E –Yield –
Creative Medical Technology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Creative Medical Technology's market cap was $4.09M on Nov 11, 2026, against $6.94M a year earlier. Over the last 5 years it ranged from $2.45M to $247.22M, with a median of $7.04M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.09M | -19.2% |
| 2025 | Dec 31, 2025 | $5.06M | +64.6% |
| 2024 | Dec 31, 2024 | $3.07M | -52.1% |
| 2023 | Dec 29, 2023 | $6.41M | -88.0% |
| 2022 | Dec 30, 2022 | $53.64M | +57.9% |
| 2021 | Dec 31, 2021 | $33.97M | -99.9% |
| 2020 | Dec 31, 2020 | $66.13B | +1990.9% |
| 2019 | Dec 31, 2019 | $3.16B | -91.9% |
| 2018 | Dec 31, 2018 | $38.82B | +440.9% |
| 2017 | Dec 29, 2017 | $7.18B | -97.2% |
| 2016 | Dec 30, 2016 | $258.35B | +25832.2% |
| 2015 | Dec 31, 2015 | $996.25M | – |
See a number that looks wrong?